|
EXEL
|
Exelixis, Inc.
|
0.93%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.92%
|
US
|
NASDAQ
|
|
BIM
|
Biomerieux SA
|
0.89%
|
FR
|
PA
|
|
MMS
|
Maximus, Inc.
|
0.79%
|
US
|
NYSE
|
|
QDEL
|
Quidel Corporation
|
0.75%
|
US
|
NASDAQ
|
|
IART
|
Integra LifeSciences Holdings Corporation
|
0.74%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.74%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.71%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.71%
|
US
|
NASDAQ
|
|
IPN
|
Ipsen SA
|
0.70%
|
FR
|
PA
|
|
091990
|
Celltrion Healthcare Co. Ltd
|
0.69%
|
KR
|
KQ
|
|
TXG
|
10x Genomics, Inc.
|
0.64%
|
US
|
NASDAQ
|
|
SYNH
|
Syneos Health, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
0.60%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
0.56%
|
US
|
NYSE
|
|
BANB
|
Bachem Holding AG
|
0.55%
|
CH
|
SW
|
|
SFZN
|
Siegfried Holding Ltd
|
0.54%
|
CH
|
SW
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
LIVN
|
LivaNova PLC
|
0.52%
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
0.49%
|
US
|
NASDAQ
|